Abstract
A device implanted in a patient could monitor blood levels of addictive substances on an intermittent or continuous basis. Excessive levels of a given substance would trigger release of an aversive chemical agent into the bloodstream, in essence creating an artificial allergy. Implications of the concept are discussed.

This publication has 1 reference indexed in Scilit: